PCG
93
2
DHI
48
3
FOXA
55
9
OXY
40
3
DOV
61
-2
IR
63
3
HSIC
54
-3
F
43
-8
AZO
46
-3
AFL
46
-3
AMP
69
-3
PEP
41
6
GM
65
-3
LUV
39
-5
AIV
68
-4
XEL
67
2
BIIB
26
2
COST
58
-2
WMT
74
2
ED
48
3
PCG
93
2
DHI
48
3
FOXA
55
9
OXY
40
3
DOV
61
-2
IR
63
3
HSIC
54
-3
F
43
-8
AZO
46
-3
AFL
46
-3
AMP
69
-3
PEP
41
6
GM
65
-3
LUV
39
-5
AIV
68
-4
XEL
67
2
BIIB
26
2
COST
58
-2
WMT
74
2
ED
48
3
Financhill
Back

Catheter Precision 10K Form

Buy
55

VTAK
Catheter Precision

Last Price:
0.42
Seasonality Move:
-5.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VTAK News And Ratings

See the #1 stock for the next 7 days that we like better than VTAK

VTAK Financial Statistics

Sales & Book Value

Annual Sales: $442K
Cash Flow: $-2.77M
Price / Cash Flow: 0
Annual Sales: $4.57
Price / Book: 0.27

Profitability

EPS (TTM): 0.88000
Net Income (TTM): $-11.68M
Gross Margin: $412K
Return on Equity: -65.84%
Return on Assets: -40.39%

Catheter Precision Earnings Forecast

Key Catheter Precision Financial Ratios

  • The Gross Profit Margin over the past 8 years for VTAK is 93.21%.
  • The Selling, General & Administrative Expenses for VTAK have been equal to 3,873.76% of Gross Profit Margin.
  • The Research & Development expenses have been 107.47% of Revenue.
  • The Interest Expense is -7.95% of Operating Income.
  • The Net Earning history of VTAK is -15,966.52% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Catheter Precision Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: VTAK
Website: catheterprecision.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 0.66
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VTAK Technical Analysis vs Fundamental Analysis

Buy
55
Catheter Precision (VTAK) is a Buy

Is Catheter Precision a Buy or a Sell?